Peripherally inserted central venous catheter for pediatric acute leukemia: A retrospective 11-year single-center experience
The Journal of Vascular Access · 2024
DOI: 10.1177/11297298231185222 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Vascular Access, 2024. Verfasst von Silvio Ligia und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Catheterization, Peripheral, Catheterization, Central Venous, Catheter-Related Infections, Central Venous Catheters. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Background
Peripherally inserted central catheters (PICCs) are successfully increasingly used in children in onco-hematologic setting. PICC insertion, especially in oncologic patients, can be associated with adverse events (thrombosis, mechanical complications, and infections). Data regarding the use of PICC, as long-term access in pediatric patients with severe hematologic diseases, are still limited.
Methods
We retrospectively evaluated the safety and efficacy of 196 PICC, inserted in 129 pediatric patients with acute leukemia diagnosed and treated at Pediatric Hematology Unit, Sapienza University of Rome.
Results
The 196 PICC analyzed were in situ for a median dwell time of 190 days (range 12–898). In 42 children, PICC was inserted twice and in 10, three times or more due to hematopoietic stem cell transplant, disease recurrence, or PICC-related complications. The overall complication rate was 34%: catheter-related bloodstream infections (CRBSI) occurred in 22% of cases after a median time of 97 days; a catheter-related thrombosis (CRT) in 3.5% and mechanical complications in 9% of cases. Premature removal for complications occurred in 30% of PICC. One death from CRBSI was observed.
Conclusions
To our knowledge, this study represents the largest cohort of pediatric patients who have inserted the PICC for acute leukemia. In our experience, PICC was a cheap, safe, and reliable device for long-term intravenous access in children with acute leukemia. This has been possible with the help of dedicated PICC team.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
- Gimema Data Center, Fondazione GIMEMA Franco Mandelli Onlus, Rome, Italy.
- Umberto 1, Polyclinic Hospital, Sapienza University of Rome, Rome, Italy.
ORCID-Profile: Silvio Ligia, Anna Maria Testi
Zitieren
APA
Ligia, S., Morano, S. G., Kaiser, F., Micozzi, A., Chistolini, A., Barberi, W., Arena, V., Piciocchi, A., Forgione, M., Gasperini, G., Berneschi, P., & Testi, A. M. (2024). Peripherally inserted central venous catheter for pediatric acute leukemia: A retrospective 11-year single-center experience. The Journal of Vascular Access. https://doi.org/10.1177/11297298231185222
Vancouver
Ligia S, Morano SG, Kaiser F, Micozzi A, Chistolini A, Barberi W, et al. Peripherally inserted central venous catheter for pediatric acute leukemia: A retrospective 11-year single-center experience. The Journal of Vascular Access. 2024. doi:10.1177/11297298231185222
BibTeX
@article{Ligia2024,
author = {Ligia, Silvio and Morano, Salvatore Giacomo and Kaiser, Francesca and Micozzi, Alessandra and Chistolini, Antonio and Barberi, Walter and Arena, Valentina and Piciocchi, Alfonso and Forgione, Maurizio and Gasperini, Giulia and Berneschi, Paola and Testi, Anna Maria},
title = {Peripherally inserted central venous catheter for pediatric acute leukemia: A retrospective 11-year single-center experience},
journal = {The Journal of Vascular Access},
year = {2024},
doi = {10.1177/11297298231185222}
}
EUVIMED